pefloxacin has been researched along with Bacterial Disease in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 35 (47.95) | 18.7374 |
1990's | 35 (47.95) | 18.2507 |
2000's | 3 (4.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, P; Cisek, EP; Cornell, CP; Elliott, NC; Gootz, TD; Haskell, SL; Hindahl, MS; Jefson, MR; Mann, DD; McGuirk, PR | 1 |
Bridges, AJ; Bucsh, R; Domagala, JM; Gogliotti, RD; Hagen, SE; Heifetz, CL; Joannides, ET; Sanchez, JP; Sesnie, JC; Shapiro, MA | 1 |
Khlebnikov, EP; Kubyshkin, VA; Terekhova, RP; Vishnevskiĭ, VA | 1 |
Cravarezza, P; Giustina, A; Ravizzola, G; Romanelli, G; Turano, A | 1 |
Gargalianos, P; Karakatsani, E; Kosmidis, J; Lanaras, L; Lelekis, M; Tsouroulas, P | 1 |
Arcese, W; Gentile, G; Giuliano, M; Martino, P; Micozzi, A; Pantosti, A | 1 |
Dofferhoff, AS; Janssen, AJ; van de Leur, JJ; Vollaard, EJ | 1 |
Arcidiacono, MM; Cogo, R; Fraschini, F; Monzani, GP; Scaglione, F; Scamazzo, F | 1 |
Colombo, M; Maggioni, A; Milani, R; Negri, L; Scalambrino, S | 1 |
Arr, M; Ludwig, E; Székely, E | 1 |
Accorsi, P; Betti, S; D'Antonio, D; Dell'Isola, M; Favalli, C; Fioritoni, G; Iacone, A; Parruti, G; Piccolomini, R; Quaglietta, AM | 1 |
Billebaud, T; Boccon-Gibod, L; Delmas, V; Villers, A | 1 |
Batchelor, D; Dubbelman, AC; Hilton, AM; Rankin, EM; Rodenhuis, S; Rutgers, EJ; Vlasveld, LT | 1 |
Bensoussan, F; Bensoussan, M; Carsenti-Etesse, H; Dellamonica, P; Forget, B | 1 |
Lagiewska, B; Mészáros, J; Pacholczyk, MJ; Rowiński, W; Szostek, M | 1 |
Fried, M; Pesková, M; Růzicka, P | 1 |
Boldueva, NG; Budagov, RS; Makarov, GF; Moiseeva, LA | 1 |
Abate, F; Balsotti, G; Cantini, L; Carlomagno, G; Cirese, E; Cosmi, EV; Di Renzo, GC; Indraccolo, R; La Sala, GB; Mearini, L; Minozzi, M; Monici Preti, PA; Scarpello, F | 1 |
Bakalova, LA; Blatun, LA; Fedorov, SM; Iakovlev, VP; Koshil', OI; Kurmanova, KB; Nestetrova, LIa; Pozdniakova, VP; Smirnova, LB; Strachunskiĭ, LS | 1 |
Navashin, PS; Smirnova, LB | 1 |
Boudiaf, M; Caulin, C; Chastang, C; Elkharrat, D; Le Corre, A; Raskine, L | 1 |
Isenmann, R; Rünzi, M | 1 |
Kapranov, NI; Khamidullina, KF; Perederko, LV; Polikarpova, SV; Postnikov, SS; Semykin, SIu | 1 |
Fomina, IP; Smirnova, LB | 1 |
Covelli, B; Lavitola, A; Lembo, M; Nani, E | 1 |
Gompel, H; Hautefeuille, P; Hecht, Y; Le Houelleur, J; Panis, Y | 1 |
Accorsi, P; Betti, S; D'Antonio, D; Dell'Isola, M; Fioritoni, G; Iacone, A; Pantalone, V; Piergallini, A; Quaglietta, AM; Recchia, A | 1 |
Glukhova, EV; Shenderov, BA; Viadro, MM | 1 |
Andremont, A; Boutan-Laroze, A; Culine, S; Droz, JP; Kattan, J; Ribrag, V | 1 |
Chua, CT; Kon, SP; Ngeow, NF; Tan, HW | 1 |
Archimbaud, E; Devaux, Y; Fiere, D; Fleurette, J; Guyotat, D; Maupas, J; Nageotte, A; Ploton, C; Thomas, X | 1 |
Chan, MK; Chan, PC; Cheng, IK; Wong, WT | 1 |
Gorski, J; Koch, H; Lange, D; Wehnert, J; Wichmann, G | 1 |
Cajozzo, A; Carbone, R; Carotenuto, M; Dammacco, F; Grana, M; La Sala, A; Mancuso, S; Perricone, R; Sgalambro, A | 1 |
Champroux, T; Gaillard de Collogny, L; Lafaye, M; Leclercq, I; Mirault, F; Russier, M | 1 |
Vanderdonckt, J | 1 |
Elran, HA; Joseph, G; Rosen, N; Rubinstein, E; Segev, S | 1 |
Meunier, F | 1 |
Auger, P; Blain, R; Leclerc, Y; Pelletier, LC; Phillips, R | 1 |
Bernard, E; Dellamonica, P; Drugeon, HB; Etesse, H; Garraffo, R | 1 |
Bricaire, F; Godeau, B; Karam, D; Leport, C; Salmon, D; Vildé, JL | 1 |
Rakovec, S; Stanisavljević, D | 1 |
Cherifi, M; Feys, J; Fisch, A; Forestier, F; Koffi-Gue, B; Salvanet-Bouccara, A | 1 |
Cengić, D; Dimitrijević, K; Dordević, D; Kaplan, M; Vranić, B | 1 |
Fong, IW | 1 |
Gonzalez, JP; Henwood, JM | 1 |
Davoulos, G; Galanakis, N; Giamarellou, H; Mandragos, K; Perdikaris, G; Sfikakis, P | 1 |
Barzilai, A; Joseph, G; Rosen, N; Rubinstein, E; Segev, S | 1 |
Beauchant, M; Becq-Giraudon, B; Breux, JP; Grollier, G; Rouffineau, J; Silvain, C | 1 |
Edlund, C; Lahnborg, G; Nord, CE | 1 |
Baur, C; Davies, BI; Maesen, FP; Teengs, JP | 2 |
Chopin, C; Fourrier, F; Lestavel, P; Savage, C | 1 |
Beuscart, C; Drugeon, H; Leroy, O; Mouton, Y; Pappo, M | 1 |
Høiby, N | 1 |
Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC | 1 |
Denamur, E; Laurans, G; Orfila, J; Suermondt, G | 1 |
Auzepy, P; Pezzano, M; Richard, C; Singlas, E; Sultan, E | 1 |
Capuzzo, M; Gritti, G; Nardini, A; Nepoti, ML; Verri, M | 1 |
Boland, DM; de Jong, D; MacLaren, DM; van Gestel, WC | 1 |
Shah, PM | 1 |
Lauwers, S; Naessens, A; Pierard, D; Vincken, W | 1 |
Modaï, J | 1 |
Mazzei, T; Nicoletti, P; Periti, P | 1 |
Wolff, M | 1 |
Desplaces, N; Gutmann, L; Houdart, R; Kitzis, M; Leonard, P; Mamoudy, P; Rouchy, J | 1 |
Beun, GD; Blijham, GH; Daniels-Bosman, MS; Debrus-Palmans, LL | 1 |
Dupon, M; Ragnaud, JM; Roche-Bezian, MC; Wone, C | 1 |
Chu, DT; Claiborne, AK; Fernandes, PB; Maleczka, RE; Nordeen, CW; Pernet, AG; Pihuleac, E | 1 |
Bertrand, A; Janbon, F; Jonquet, O; Jourdan, J; Santoni, A | 1 |
Gracida, C; Melchor, JL | 1 |
Ajayi, SO; Kadiri, S; Toki, RA | 1 |
7 review(s) available for pefloxacin and Bacterial Disease
Article | Year |
---|---|
Clinical observations with Péflacine.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cross Infection; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pefloxacin; Prospective Studies; Treatment Outcome | 1993 |
[Pharmacokinetic basis for the use of pefloxacin in severe forms of infectious-inflammatory diseases].
Topics: Anti-Infective Agents; Bacterial Infections; Humans; Inflammation; Intestinal Absorption; Pefloxacin | 1998 |
[Pefloxacin (Abactal): role in modern therapy of bacterial infections].
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Humans; Pefloxacin | 2000 |
[Surgical treatment of toxic megacolon complicating pseudomembranous colitis. Apropos of a case, review of the literature].
Topics: Aged; Bacterial Infections; Colectomy; Enterocolitis, Pseudomembranous; Female; Hip Prosthesis; Humans; Megacolon, Toxic; Pefloxacin; Postoperative Complications | 1992 |
[Prevention of infectious complications of major upper respiratory and digestive tract surgery by the combination of pefloxacin-amoxicillin-clavulanic acid].
Topics: Adult; Aged; Amoxicillin; Bacterial Infections; Clavulanic Acids; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Laryngectomy; Male; Middle Aged; Pefloxacin; Pharyngectomy; Surgical Flaps | 1990 |
Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Topics: Animals; Bacteria; Bacterial Infections; Humans; Pefloxacin | 1989 |
Quinolones.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Enoxacin; Humans; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
22 trial(s) available for pefloxacin and Bacterial Disease
Article | Year |
---|---|
Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients.
Topics: Aged; Antineoplastic Agents; Bacterial Infections; Feces; Gram-Negative Bacteria; Humans; Middle Aged; Neutropenia; Pefloxacin | 1995 |
Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections.
Topics: Adult; Bacterial Infections; Bronchi; Bronchoalveolar Lavage Fluid; Chronic Disease; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; Pefloxacin; Respiratory Tract Infections; Staphylococcus aureus | 1995 |
Clinical observations with Péflacine.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cross Infection; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pefloxacin; Prospective Studies; Treatment Outcome | 1993 |
Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
Topics: Adult; Aged; Agranulocytosis; Anti-Infective Agents; Bacteremia; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Feces; Female; Fever; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Neutropenia; Ofloxacin; Pefloxacin | 1994 |
[Prospective randomized comparison of the effects of pefloxacin and clindamycin with cefoxitin after hepatobiliary and pancreatic operations].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Biliary Tract Surgical Procedures; Cefoxitin; Clindamycin; Female; Humans; Liver; Male; Middle Aged; Pancreas; Pefloxacin; Postoperative Complications; Prospective Studies | 1995 |
Efficacy and tolerability of brodimoprim at two different dosage schedules in the treatment of acute uncomplicated bacterial cystitis: comparative study vs. pefloxacin.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Cystitis; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pefloxacin; Treatment Outcome; Trimethoprim | 1996 |
[Pefloxacin mesylate--clinical effectiveness in various forms of infectious-inflammatory diseases].
Topics: Anti-Infective Agents; Bacterial Infections; Bone Diseases; Brucellosis; Female Urogenital Diseases; Humans; Inflammation; Male Urogenital Diseases; Meningitis, Bacterial; Pefloxacin; Soft Tissue Infections; Treatment Outcome; Typhoid Fever; Yersinia Infections | 1997 |
[News on antibiotic prophylaxis of necrosis infection in severe acute pancreatitis: the Italian viewpoint].
Topics: Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Female; Humans; Imipenem; Infusions, Intravenous; Italy; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Pefloxacin; Thienamycins | 1999 |
[Evaluation of tolerance and efficacy of pefloxacin in the treatment and prevention of severe infections in children with mucoviscidosis and aplastic anemia].
Topics: Adolescent; Anemia, Aplastic; Anti-Infective Agents; Bacterial Infections; Child; Cystic Fibrosis; Drug Monitoring; Female; Humans; Pefloxacin | 2000 |
Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacteremia; Bacterial Infections; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Norfloxacin; Pefloxacin | 1992 |
Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind study.
Topics: Adult; Aged; Antineoplastic Agents; Bacterial Infections; Colistin; Double-Blind Method; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Neutropenia; Pefloxacin; Vancomycin | 1991 |
[A clinical trial of pefloxacin (Abaktal) in the treatment of acute pyelonephritis].
Topics: Acute Disease; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pefloxacin; Pyelonephritis; Randomized Controlled Trials as Topic | 1990 |
Pefloxacin in the antibacterial treatment of immunodepressed patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Bacterial Infections; Humans; Immune Tolerance; Middle Aged; Multicenter Studies as Topic; Neoplasms; Pefloxacin | 1990 |
Comparison of pefloxacin with ceftazidime in severe bronchopulmonary infections.
Topics: Administration, Oral; Bacterial Infections; Bronchopneumonia; Ceftazidime; Drug Resistance, Microbial; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pefloxacin; Prospective Studies; Remission Induction | 1990 |
Double-blind comparison of pefloxacin and cefazolin as prophylaxis in elective cardiovascular surgery.
Topics: Aged; Bacterial Infections; Cefazolin; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Male; Pefloxacin; Staphylococcal Infections; Time Factors | 1990 |
The role of fluoroquinolones in the management of skin, soft tissue, and bone infections.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Dermatitis; Enoxacin; Gram-Negative Bacteria; Humans; Ofloxacin; Osteomyelitis; Pefloxacin | 1989 |
Pefloxacin versus ceftazidime in the treatment of a variety of gram-negative-bacterial infections.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Female; Gram-Negative Bacteria; Humans; Injections, Intravenous; Male; Middle Aged; Pefloxacin; Random Allocation; Time Factors | 1989 |
[Initial antibiotherapy in severe bacterial bronchopneumopathies. Randomized study of a new quinolone: pefloxacin].
Topics: Anti-Infective Agents; Bacterial Infections; Bronchopneumonia; Humans; Norfloxacin; Pefloxacin | 1986 |
[Controlled randomized prospective study of a ceftazidime-pefloxacin combination versus a ceftazidime-amikacin combination in the empirical treatment of nosocomial pneumonias and septicemias of resuscitation. Preliminary results].
Topics: Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation | 1988 |
Treatment of respiratory tract infections with pefloxacin in critically ill patients hospitalized in a surgical intensive care unit.
Topics: Bacterial Infections; Clinical Trials as Topic; Critical Care; Drug Resistance, Microbial; Humans; Norfloxacin; Pefloxacin; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections | 1987 |
Prophylactic antibiotics in renal transplantation.
Topics: 4-Quinolones; Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Cephalothin; Fluoroquinolones; Humans; Kidney Transplantation; Longitudinal Studies; Pefloxacin; Prospective Studies; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Quinolones for short-term treatment of uncomplicated urinary tract infection.
Topics: 4-Quinolones; Administration, Oral; Adult; Anti-Infective Agents; Bacterial Infections; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nigeria; Ofloxacin; Pefloxacin; Single-Blind Method; Time Factors; Treatment Outcome; Urinary Tract Infections | 1999 |
45 other study(ies) available for pefloxacin and Bacterial Disease
Article | Year |
---|---|
Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Aerobiosis; Anaerobiosis; Animals; Anti-Infective Agents; Bacterial Infections; Cattle; Cattle Diseases; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Molecular Structure; Pasteurella Infections; Quinolones; Structure-Activity Relationship; Swine; Swine Diseases | 1992 |
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Bacterial Infections; Female; Injections, Subcutaneous; Mice; Microbial Sensitivity Tests; Photosensitivity Disorders; Structure-Activity Relationship | 1992 |
[Clinical and laboratory investigation of pefloxacin used prophylactically in operations on the liver].
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Echinococcosis, Hepatic; Female; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Mycoses; Pefloxacin; Postoperative Complications; Treatment Outcome | 2009 |
Pefloxacin in the treatment of acute severe infections in hospitalized patients. Clinical and bacteriological evaluation.
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Clinical Trials as Topic; Female; Humans; Inpatients; Male; Middle Aged; Pefloxacin; Treatment Outcome | 1989 |
Serious, life-threatening infections: results with pefloxacin.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Humans; Pefloxacin; Severity of Illness Index; Treatment Failure; Treatment Outcome | 1989 |
Effects of norfloxacin or pefloxacin on the oral and intestinal microflora of bone marrow transplant patients.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacterial Infections; Bone Marrow Transplantation; Female; Humans; Male; Norfloxacin; Pefloxacin; Postoperative Complications; Transplantation, Homologous | 1989 |
Pefloxacin in the treatment of severe infections in gynecological cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Female; Genital Neoplasms, Female; Humans; Middle Aged; Pefloxacin; Postoperative Complications | 1994 |
[Complications of prostatic biopsy. An analysis of a series of 4764 biopsies].
Topics: Anti-Bacterial Agents; Bacterial Infections; Biopsy; France; Humans; Male; Norfloxacin; Pefloxacin; Prostate; Ultrasonography, Interventional | 1993 |
Catheter-related complications in 52 patients treated with continuous infusion of low dose recombinant interleukin-2 via an implanted central venous catheter.
Topics: Adult; Aged; Bacterial Infections; Catheterization, Central Venous; Catheters, Indwelling; Female; Humans; Infusions, Intravenous; Interleukin-2; Male; Middle Aged; Neoplasms; Pefloxacin; Recombinant Proteins; Thrombosis; Treatment Outcome | 1994 |
Release of pefloxacin bonded on catheters after intraperitoneal implantation in mice.
Topics: Animals; Anti-Infective Agents; Bacterial Adhesion; Bacterial Infections; Catheterization; Drug Implants; Female; Foreign Bodies; Half-Life; Mice; Pefloxacin; Peritoneal Cavity; Surface Properties | 1995 |
Bacterial infections transmitted from the donor: antibiotic prophylaxis in the donor.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacterial Infections; Cadaver; Candida albicans; Chi-Square Distribution; Humans; Incidence; Kidney Transplantation; Nephrectomy; Pefloxacin; Retrospective Studies; Tissue Donors | 1996 |
[Evaluation of the effectiveness of the use of pefloxacin in combined radiation-thermal injury].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Burns; Doxycycline; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Pefloxacin; Radiation Injuries, Experimental | 1995 |
Relevance in the emergency department of a decisional algorithm for outpatient care of women with acute pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Algorithms; Ambulatory Care; Anti-Infective Agents; Bacterial Infections; Confidence Intervals; Decision Making; Emergency Service, Hospital; Feasibility Studies; Female; France; Humans; Injections, Intravenous; Length of Stay; Middle Aged; Observation; Pefloxacin; Pregnancy; Pregnancy Complications, Infectious; Prognosis; Prospective Studies; Pyelonephritis; Software; Treatment Outcome | 1999 |
Evaluation of pefloxacin activity against recent clinical isolates.
Topics: Anti-Infective Agents; Bacterial Infections; Humans; Microbial Sensitivity Tests; Pefloxacin | 1991 |
[Microbial ecology of laboratory animals as a model in evaluation of the immunomodulating and antimicrobial agents].
Topics: Adjuvants, Immunologic; Animals; Bacillus; Bacterial Adhesion; Bacterial Infections; Colitis; Colon; Cyclophosphamide; Disease Models, Animal; Models, Biological; Neutropenia; Pefloxacin; Polysaccharides, Bacterial; Rats; Rats, Wistar | 1992 |
[Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Pefloxacin; Piperacillin; Prospective Studies; Renal Insufficiency; Vancomycin | 1992 |
Oral pefloxacin in the treatment of CAPD peritonitis.
Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1992 |
Clinical experience with pefloxacin in patients with urinary tract infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Pefloxacin; Urinary Tract Infections | 1990 |
Pefloxacin efficacy in gram-negative bacillary meningitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Child; Child, Preschool; Female; Gram-Negative Bacteria; Humans; Infant; Injections, Intravenous; Male; Meningitis; Microbial Sensitivity Tests; Middle Aged; Pefloxacin | 1990 |
Prevention of infections in neutropenic patients with pefloxacin.
Topics: Administration, Oral; Bacterial Infections; Humans; Neutropenia; Pefloxacin; Risk Factors | 1990 |
Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis.
Topics: Administration, Oral; Adult; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Escherichia coli; Female; Humans; Male; Ofloxacin; Osteomyelitis; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 1989 |
[Chronic bone infections after surgery. Treatment with the new quinolones].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bone Diseases; Ciprofloxacin; Female; Humans; Male; Middle Aged; Orthopedics; Pefloxacin; Postoperative Complications; Prospective Studies | 1989 |
[New possibilities in the care of surgical infections (personal experience with pefloxacin)].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Female; Humans; Male; Middle Aged; Pefloxacin; Postoperative Complications | 1989 |
[Bacterial endophthalmitis: treatment with a combination of fosfomycin and pefloxacin apropos of 9 cases].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Drug Therapy, Combination; Endophthalmitis; Female; Fosfomycin; Humans; Male; Middle Aged; Pefloxacin | 1989 |
[Pefloxacin in the treatment of septicemia, purulent meningitis and salmonellosis].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Child; Female; Humans; Male; Meningitis; Middle Aged; Pefloxacin; Salmonella Infections; Sepsis | 1989 |
Pefloxacin treatment of meningitis caused by gram-negative bacteria.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Child; Female; Gram-Negative Bacteria; Humans; Male; Meningitis; Middle Aged; Pefloxacin; Prognosis | 1989 |
[Can septicemia and ascitic fluid infections in cirrhotic patients be treated by the oral route alone?].
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Pefloxacin; Prospective Studies; Sepsis; Time Factors | 1989 |
The efficacy of pefloxacin in comparison to gentamicin in the treatment of experimentally induced peritonitis in rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Clostridium perfringens; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gentamicins; Klebsiella pneumoniae; Male; Metronidazole; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Peritonitis; Proteus mirabilis; Rats; Rats, Inbred Strains | 1986 |
[New oral quinolone compounds in chronic bronchitis].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Naphthyridines; Neisseria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pneumococcal Infections; Pseudomonas Infections; Quinolines; Streptococcus pneumoniae | 1986 |
Clinical uses of nalidixic acid analogues: the fluoroquinolones.
Topics: Administration, Oral; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Male; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Topoisomerase II Inhibitors | 1986 |
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Escherichia coli; Female; Kanamycin; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Peritonitis; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus | 1986 |
[In vitro activity of 3 fluoroquinolones on Branhamella catarrhalis].
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Pefloxacin; Respiratory Tract Infections | 1988 |
Pharmacokinetics of pefloxacin and amikacin administered simultaneously to intensive care patients.
Topics: Aged; Amikacin; Bacterial Infections; Drug Interactions; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Pefloxacin | 1988 |
[Pefloxacin in the treatment of severe infections in intensive care].
Topics: Abdomen; Bacterial Infections; Drug Evaluation; Humans; Intensive Care Units; Pefloxacin; Respiratory Tract Infections; Surgical Wound Infection | 1988 |
Pefloxacin--a laboratory and clinical evaluation of a new quinolone. Based on papers presented at the 14th International Congress of Chemotherapy. Kyoto, Japan, June 1985.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Humans; Norfloxacin; Pefloxacin | 1986 |
Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bronchopneumonia; Cholangitis; Drug Evaluation; Female; Humans; Intensive Care Units; Male; Middle Aged; Norfloxacin; Pefloxacin; Pneumonia | 1986 |
[Pefloxacin: evaluation and clinical prospects].
Topics: Bacterial Infections; Evaluation Studies as Topic; Female; Humans; Lung Diseases; Male; Meningitis; Norfloxacin; Osteomyelitis; Pefloxacin; Urethritis; Urinary Tract Infections | 1986 |
Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
Topics: Anti-Infective Agents; Bacterial Infections; Bronchitis; Ciprofloxacin; Enoxacin; Female; Humans; Male; Middle Aged; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1986 |
Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
[Therapeutic contribution of the new quinolones].
Topics: Anti-Infective Agents; Bacterial Infections; Biotransformation; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Therapy, Combination; Humans; Kinetics; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Pefloxacin in the treatment of 24 suppurative infections.
Topics: Acute Disease; Bacterial Infections; Chronic Disease; Humans; Middle Aged; Pefloxacin; Suppuration | 1987 |
Monotherapy with pefloxacin in neutropenic febrile patients.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Fever; Humans; Middle Aged; Neoplasms; Neutropenia; Pefloxacin | 1987 |
Management of peritonitis related to chronic ambulatory peritoneal dialysis (CAPD) using two daily intraperitoneal injections of 400 mg pefloxacin.
Topics: Bacteria; Bacterial Infections; Humans; Injections, Intraperitoneal; Microbial Sensitivity Tests; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1987 |
Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents.
Topics: Acinetobacter; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli; Female; Fluorine; Fluoroquinolones; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus; Streptococcus; Structure-Activity Relationship | 1985 |
[Pefloxacin: clinical experience].
Topics: Acinetobacter Infections; Adult; Aged; Bacterial Infections; Enterobacteriaceae Infections; Enterococcus faecalis; Female; Humans; Male; Meningitis; Middle Aged; Norfloxacin; Osteitis; Pefloxacin; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1985 |